Literature DB >> 9070702

Prorenin and active renin concentrations in plasma and ascites during severe ovarian hyperstimulation syndrome.

A Delbaere1, P J Bergmann, C Gervy-Decoster, M Camus, V de Maertelaer, Y Englert.   

Abstract

The pathophysiology of ovarian hyperstimulation syndrome (OHSS) remains unclear. Several lines of evidence indicate that OHSS is associated with a stimulation of the renin-angiotensin system (RAS), but its functional significance as well as its role in the pathogenesis of the syndrome are not yet determined. OHSS is associated with high plasma and ascitic concentrations of total renin, renin activity (RA) and angiotensin II (Ang II). Their ovarian or renal origin is, however, still a matter of debate. To clarify these issues further, total renin, active renin, prorenin, RA and aldosterone were measured in plasma and ascites of nine patients who developed severe OHSS after in-vitro fertilization. Blood and ascites were sampled simultaneously during therapeutic paracentesis. Total renin and prorenin concentrations were significantly higher in the ascites (mean concentration +/- SE respectively of 5920 +/- 1430 mIU/l and 5250 +/- 1350 mIU/l) than in the plasma (respectively 3060 +/- 740 mIU/l and 2000 +/- 460 mIU/l) (P = 0.020 and 0.017 respectively). Conversely, active renin and RA concentrations tended to be lower, although not statistically significantly so in the ascites (respectively 670 +/- 190 mIU/l and 47 +/- 11 ng Ang I/ml/h) than in the plasma (respectively 1060 +/- 370 mIU/l and 75 +/- 21 ng Ang I/ml/h). Aldosterone concentrations were significantly higher in the serum (2609 +/- 374 pg/ml) than in the ascites (2025 +/- 347 pg/ml) (P = 0.015). The concentration gradient between plasma and ascites for total renin and prorenin supports the hypothesis of their ovarian origin in ascites and, to a large extent, in plasma, while it is likely that the high plasma active renin and RA concentrations reflect a peripheral activation of the RAS. In conclusion, the present findings are consistent with a marked stimulation of both ovarian and renal RAS during OHSS.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9070702     DOI: 10.1093/humrep/12.2.236

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  5 in total

Review 1.  Understanding ovarian hyperstimulation syndrome.

Authors:  Anne Delbaere; Guillaume Smits; Anne De Leener; Sabine Costagliola; Gilbert Vassart
Journal:  Endocrine       Date:  2005-04       Impact factor: 3.633

2.  What is the best predictor of severe ovarian hyperstimulation syndrome in IVF? A cohort study.

Authors:  Theoni B Tarlatzi; Christos A Venetis; Fabienne Devreker; Yvon Englert; Anne Delbaere
Journal:  J Assist Reprod Genet       Date:  2017-07-14       Impact factor: 3.412

Review 3.  New insights into the pathophysiology of ovarian hyperstimulation syndrome. What makes the difference between spontaneous and iatrogenic syndrome?

Authors:  A Delbaere; G Smits; O Olatunbosun; R Pierson; G Vassart; S Costagliola
Journal:  Hum Reprod       Date:  2004-01-29       Impact factor: 6.918

Review 4.  Pharmacologic Interventions in Preventing Ovarian Hyperstimulation Syndrome: A Systematic Review and Network Meta-Analysis.

Authors:  Jun-Liang Guo; Duo-Duo Zhang; Yue Zhao; Dan Zhang; Xi-Meng Zhang; Can-Quan Zhou; Shu-Zhong Yao
Journal:  Sci Rep       Date:  2016-01-11       Impact factor: 4.379

5.  Ovarian Hyperstimulation Syndrome with pleural effusion: a case report.

Authors:  Recep Yildizhan; Ertan Adali; Ali Kolusari; Mertihan Kurdoglu; Cagdas Ozgokce; Fulya Adali
Journal:  Cases J       Date:  2008-11-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.